Table 4
Leading sources of support for UK respiratory medicine research, 1996–2000
| Funding source | No of papers | % |
|---|---|---|
| UK government, of which: | 1558 | 22.1 |
| Medical Research Council (MRC) | 792 | 11.2 |
| Department of Health (DoH) | 270 | 3.8 |
| Biotechnology & Biological Sciences Research Council | 136 | 1.9 |
| UK private-non-profit organisations, of which: | 2047 | 29.1 |
| Wellcome Trust | 639 | 9.1 |
| National Asthma Campaign | 297 | 4.2 |
| British Lung Foundation | 200 | 2.8 |
| British Heart Foundation | 165 | 2.3 |
| Cystic Fibrosis Research Trust | 126 | 1.8 |
| Cancer Research Campaign (now part of Cancer Research UK) | 103 | 1.5 |
| Industry, of which: | 1532 | 21.7 |
| GlaxoWellcome plc | 451 | 6.4 |
| AstraZeneca plc | 161 | 2.3 |
| International and foreign organisations, of which: | 1405 | 19.9 |
| European Union | 231 | 3.3 |
| US National Institutes of Health | 225 | 3.2 |
| No funding acknowledged | 2739 | 38.9 |
| Total papers | 7046 | 100.0 |
